Farallon Capital Management’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-70,429
| Closed | -$547K | – | 146 |
|
|
2025
Q1 | $547K | Buy |
70,429
+35,429
| +101% | +$275K | ﹤0.01% | 89 |
|
|
2024
Q4 | $795K | Sell |
35,000
-37,413
| -52% | -$850K | ﹤0.01% | 91 |
|
|
2024
Q3 | $406K | Sell |
72,413
-5
| -0% | -$28 | ﹤0.01% | 106 |
|
|
2024
Q2 | $972K | Hold |
72,418
| – | – | ﹤0.01% | 102 |
|
|
2024
Q1 | $1.27M | Hold |
72,418
| – | – | 0.01% | 114 |
|
|
2023
Q4 | $1.49M | Hold |
72,418
| – | – | 0.01% | 100 |
|
|
2023
Q3 | $1.2M | Buy |
+72,418
| New | +$1.2M | 0.01% | 109 |
|
|
2017
Q3 | – | Sell |
-267
| Closed | -$1.2M | – | 86 |
|
|
2017
Q2 | $1.2M | Buy |
+267
| New | +$1.2M | 0.01% | 79 |
|